Hesselberth J, Robertson M P, Jhaveri S, Ellington A D
Department of Chemistry and Biochemistry, Institute for Cell and Molecular Biology, University of Texas at Austin, 78712, USA.
J Biotechnol. 2000 Mar;74(1):15-25. doi: 10.1016/s1389-0352(99)00005-7.
In vitro selection methods have proven to be extraordinarily adept at generating a wide variety of nucleic acid-binding species (aptamers) and catalysts (ribozymes). To date, selected nucleic acids have primarily been of academic interest. However, just as antibodies have proven utility as 'universal receptors' that can be crafted against a huge variety of ligands and can be readily adapted to diagnostic assays, aptamers may yet find application in assays. A new class of research reagents, aptazymes, are not mere mimics of antibodies but in fact allow the direct transduction of molecular recognition to catalysis. Aptamers and aptazymes may prove to be uniquely useful for the development of chip arrays for the detection and quantitation of a wide range of molecules in organismal proteomes and metabolomes.
体外筛选方法已被证明在生成各种各样的核酸结合物种(适体)和催化剂(核酶)方面极为擅长。迄今为止,所筛选出的核酸主要具有学术研究价值。然而,正如抗体已被证明可作为“通用受体”,能够针对各种各样的配体进行设计,并且易于应用于诊断检测一样,适体可能也会在检测中找到应用。一类新型的研究试剂——适体酶,并非仅仅是抗体的模仿物,实际上它能将分子识别直接转化为催化作用。适体和适体酶可能被证明对于开发用于检测和定量生物体蛋白质组和代谢组中多种分子的芯片阵列具有独特的用途。